Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PUMP-IT study of hepatic arterial infusion pump chemotherapy plus systemic chemotherapy for potentially resectable colorectal liver metastases
NL-OMON60134Phase 3Active, not recruiting
- Sponsor
- Netherlands Cancer Institute
- Start
- Sep 2020
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of irinotecan, fluorouracil, folinic acid and oxaliplatin, sponsored by Netherlands Cancer Institute. Started Sep 2020; status: active, not recruiting.
02
Drugs
irinotecanfluorouracilfolinic acidoxaliplatin
Beyond the preview
Go deeper on NL-OMON60134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60134.